Search

Search Results
Results 501 - 510 of 821 for Male breast cancer
  • News - 6 Oct 2026
    A small Italian study examined whether women facing heightened bone-loss risks are getting enough calcium from their diets, with particular attention to breast cancer patients receiving endocrine...
  • Drug - 24 Aug 2026
    Consumer Medicine Information (CMI) about Truqap intended for persons living in Australia.
  • News - 19 Aug 2026
    A large prospective U.S. study followed more than 111,000 adults to examine whether sugar-sweetened and artificially sweetened beverage intake was associated with gastric cancer incidence. Researchers...
  • Drug - 19 Aug 2026
    Consumer Medicine Information (CMI) about DBL Gemcitabine Injection intended for persons living in Australia.
  • Drug - 14 Aug 2026
    Consumer Medicine Information (CMI) about Tagrisso intended for persons living in Australia.
  • Drug - 30 Jul 2026
    Consumer Medicine Information (CMI) about Dutasteride/tamsulosin Viatris 500/400 intended for persons living in Australia.
  • Drug - 6 Jul 2026
    Consumer Medicine Information (CMI) about Itovebi intended for persons living in Australia.
  • News - 26 Jun 2026
    As people continue to live longer and the survival rate of cancer diagnoses increases, researchers from VCU Massey Comprehensive Cancer Center led a multi-decade analysis studying the rates of...
  • Drug - 26 May 2026
    Consumer Medicine Information (CMI) about Duodart intended for persons living in Australia.
  • Drug - 26 May 2026
    Consumer Medicine Information (CMI) about Doubluts intended for persons living in Australia.

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.